We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GlaxoSmithKline Slammed With $90 Million Verdict for Patent Infringement
GlaxoSmithKline Slammed With $90 Million Verdict for Patent Infringement
Pharma giant GlaxoSmithKline infringed upon UK-based Vectura’s patent on particle manufacturing and must pay the company $89.7 million, a federal jury in Delaware ruled.